Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany

European Journal of Health Economics

Volumn 16, Issue 5, 2015, Pages 471-488

  Damm, Oliver ^a   Eichner, Martin ^b,c   Rose, Markus Andreas ^d   Knuf, Markus ^e,f   Wutzler, Peter ^g   Liese, Johannes Günter ^h   Krüger, Hagen ⁱ   Greiner, Wolfgang ^a  

^a BIELEFELD UNIVERSITY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c EPIMOS GMBH   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e DR HORST SCHMIDT KLINIKEN   (Germany)

^f UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^g JENA UNIVERSITY HOSPITAL   (Germany)

^h UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

ⁱ ASTRAZENECA   (United Kingdom)

Author keywords

Children; Cost effectiveness; Dynamic transmission model; Germany; Influenza; Vaccination

Indexed keywords

ANALGESIC AGENT; ANTIINFECTIVE AGENT; INFLUENZA VACCINE; LIVE VACCINE;

ADOLESCENT; CHILD; COST BENEFIT ANALYSIS; ECONOMICS; GERMANY; HUMAN; INFLUENZA, HUMAN; INTRANASAL DRUG ADMINISTRATION; OTITIS MEDIA; PNEUMONIA; PRESCHOOL CHILD; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; STATISTICAL MODEL;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ANALGESICS; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; GERMANY; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, ECONOMETRIC; OTITIS MEDIA; PNEUMONIA; PUBLIC HEALTH; QUALITY-ADJUSTED LIFE YEARS; VACCINES, ATTENUATED;

EID: 84930522668     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-014-0586-4     Document Type: Article

References (89)

1. Keech, M., Beardsworth, P.: The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics 26(11), 911–924 (2008)
2. Molinari, N.A., Ortega-Sanchez, I.R., Messonnier, M.L., Thompson, W.W., Wortley, P.M., Weintraub, E., Bridges, C.B.: The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25(27), 5086–5096 (2007)
3. Szucs, T., Behrens, M., Volmer, T.: Public health costs of influenza in Germany 1996—a cost-of-illness analysis. Med. Klin. (Munich) 96(2), 63–70 (2001)
4. Esposito, S., Cantarutti, L., Molteni, C.G., Daleno, C., Scala, A., Tagliabue, C., Pelucchi, C., Giaquinto, C., Principi, N.: Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J. Infect. 62, 379–387 (2011)
5. Nair, H., Brooks, W.A., Katz, M., Roca, A., Berkley, J.A., Madhi, S.A., Simmerman, J.M., Gordon, A., Sato, M., Howie, S., Krishnan, A., Ope, M., Lindblade, K.A., Carosone-Link, P., Lucero, M., Ochieng, W., Kamimoto, L., Dueger, E., Bhat, N., Vong, S., Theodoratou, E., Chittaganpitch, M., Chimah, O., Balmaseda, A., Buchy, P., Harris, E., Evans, V., Katayose, M., Gaur, B., O‘Callaghan-Gordo, C., Goswami, D., Arvelo, W., Venter, M., Briese, T., Tokarz, R., Widdowson, M.A., Mounts, A.W., Breiman, R.F., Feikin, D.R., Klugman, K.P., Olsen, S.J., Gessner, B.D., Wright, P.F., Rudan, I., Broor, S., Simões, E.A., Campbell, H.: Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 378(9807), 1917–1930 (2011)
6. Fairbrother, G., Cassedy, A., Ortega-Sanchez, I.R., Szilagyi, P.G., Edwards, K.M., Molinari, N.A., Donauer, S., Henderson, D., Ambrose, S., Kent, D., Poehling, K., Weinberg, G.A., Griffin, M.R., Hall, C.B., Finelli, L., Bridges, C., Staat, M.A.: New Vaccine Surveillance Network (NVSN): high costs of influenza: direct medical costs of influenza disease in young children. Vaccine 28(31), 4913–4919 (2010)
7. Ampofo, K., Gesteland, P.H., Bender, J., Mills, M., Daly, J., Samore, M., Byington, C., Pavia, A.T., Srivastava, R.: Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 118(6), 2409–2417 (2006)
8. Poehling, K.A., Edwards, K.M., Weinberg, G.A., Szilagyi, P., Staat, M.A., Iwane, M.K., Bridges, C.B., Grijalva, C.G., Zhu, Y., Bernstein, D.I., Herrera, G., Erdman, D., Hall, C.B., Seither, R., Griffin, M.R.: New Vaccine Surveillance Network: the underrecognized burden of influenza in young children. N. Engl. J. Med. 355(1), 31–40 (2006)
9. Heikkinen, T., Silvennoinen, H., Peltola, V., Ziegler, T., Vainionpaa, R., Vuorinen, T., Kainulainen, L., Puhakka, T., Jartti, T., Toikka, P., Lehtinen, P., Routi, T., Juven, T.: Burden of influenza in children in the community. J. Infect. Dis. 190(8), 1369–1373 (2004)
10. Principi, N., Esposito, S., Gasparini, R., Marchisio, P., Crovari, P.: Flu–Flu Study Group: burden of influenza in healthy children and their households. Arch. Dis. Child. 89(11), 1002–1007 (2004)
11. Fraaij, P.L., Heikkinen, T.: Seasonal influenza: the burden of disease in children. Vaccine 29(43), 7524–7528 (2011)
12. Rothberg, M.B., Haessler, S.D., Brown, R.B.: Complications of viral influenza. Am. J. Med. 121(4), 258–264 (2008)
13. Wutzler, P.: Prophylactic influenza vaccination: What is the situation in Germany? Dtsch. Med. Wochenschr. 131(9), 453–457 (2006)
14. Ambrose, C.S., Wu, X., Knuf, M., Wutzler, P.: The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies. Vaccine 30(5), 886–892 (2012)
15. Osterholm, M.T., Kelley, N.S., Sommer, A., Belongia, E.A.: Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 12(1), 36–44 (2012)
16. Ambrose, C.S., Wu, X., Belshe, R.B.: The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination. Pediatr. Infect. Dis. J. 29(9), 806–811 (2010)
17. Ambrose, C.S., Yi, T., Walker, R.E., Connor, E.M.: Duration of protection provided by live attenuated influenza vaccine in children. Pediatr. Infect. Dis. J. 27(8), 744–748 (2008)
18. Tam, J.S., Capeding, M.R., Lum, L.C., Chotpitayasunondh, T., Jiang, Z., Huang, L.M., Lee, B.W., Qian, Y., Samakoses, R., Lolekha, S., Rajamohanan, K.P., Narayanan, S.N., Kirubakaran, C., Rappaport, R., Razmpour, A., Gruber, W.C., Forrest, B.D.: Pan-Asian CAIV-T Pediatric Efficacy Trial Network: efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr. Infect. Dis. J. 26(7), 619–628 (2007)
19. Flood, E.M., Ryan, K.J., Rousculp, M.D., Beusterien, K.M., Block, S.L., Hall, M.C., Mahadevia, P.J.: A survey of children’s preferences for influenza vaccine attributes. Vaccine 29(26), 4334–4340 (2011)
20. SAGE Influenza Working Group: Proposed revisions to the 2005 WHO position paper on influenza vaccines, 2012 (2012)
21. Robert Koch-Institut (RKI): Bericht zur Epidemiologie der Influenza in Deutschland Saison 2010/11. Berlin (2011)
22. Mereckiene, J., Cotter, S., D’Ancona, F., Giambi, C., Nicoll, A., Levy-Bruhl, D., Lopalco, P.L., Weber, J.T., Johansen, K., Dematte, L., Salmaso, S., Stefanoff, P., Greco, D., Dorleans, F., Polkowska, A., O’Flanagan, D.: VENICE project gatekeepers group: differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008–2009. Eur. Surveill. 15(44) (2010)
23. Usonis, V., Anca, I., André, F., Chlibek, R., Ivaskeviciene, I., Mangarov, A., Mészner, Z., Prymula, R., Simurka, P., Tamm, E., Tesović, G.: Central European Vaccination Advisory Group: Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children. BMC Infect. Dis. 10, 168 (2010)
24. O’Flanagan, D., Cotter, S., Mereckiene, J.: Seasonal influenza vaccination in Europe: vaccination policy and vaccination coverage. Summary of VENICE surveys. ECDC and WHO EURO Annual Influenza Meeting. Warsaw, Poland (2012)
25. Bigl, S.: Mitteilungen der Sächsischen Impfkommission (SIKO). Ärzteblatt Sachsen 2010(1), 13–17 (2010)
26. Joint Committee on Vaccination and Immunisation: JCVI statement on the annual influenza vaccination programme—extension of the programme to children (2012)
27. Glezen, W.O., Manjusha, J.G., Kozinetz, C.A., Piedra, P.A.: Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding and epidemic caused by 3 new influenza virus variants. J. Infect. Dis. 202(11), 1626–1633 (2010)
28. Loeb, M., Russell, M.L., Moss, L., Fonseca, K., Fox, J., Earn, D.J.D., Aoki, F., Horsman, G., van Caeseele, P., Chokani, K., Vooght, M., Babiuk, L., Webby, R., Walter, S.D.: Effect of influenza vaccination of children on infection rates in Hutterite communities. A randomized trial. JAMA 303(10), 943–950 (2010)
29. Ghendon, Y.Z., Kaira, A.N., Elshina, G.A.: The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol. Infect. 134, 71–78 (2006)
30. Jordan, R., Connock, M., Albon, E., Fry-Smith, A., Olowokure, B., Hawker, J., Burls, A.: Universal vaccination of children against influenza: Are there indirect benefits to the community? A systematic review of the evidence. Vaccine 24(8), 1047–1062 (2006)
31. Reichert, T.A., Sugaya, N., Fedson, D.S., Glezen, W.P., Simonsen, L., Tashiro, M.: The Japanese experience with vaccinating schoolchildren against influenza. N. Engl. J. Med. 344(12), 889–896 (2001)
32. Rudenko, L.G., Slepushkin, A.N., Monto, A.S., Kendal, A.P., Grigorieva, E.P., Burtseva, E.P., Rekstin, A.R., Beljaev, A.L., Bragina, V.E., Cox, N., Ghendon, Y.Z., Alexandrova, G.I.: Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J. Infect. Dis. 168, 881–887 (1993)
33. Cohen, S.A., Chui, K.K., Naumova, E.N.: Influenza vaccination in young children reduces influenza-associated hospitalizations in older adults, 2002–2006. J. Am. Geriatr. Soc. 59(2), 327–332 (2011)
34. Rose, M.A., Damm, O., Greiner, W., Knuf, M., Wutzler, P., Liese, J.G., Krüger, H., Wahn, U., Schaberg, T., Schwehm, M., Kochmann, T.F., Eichner, M.: The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. BMC Infect. Dis. 14, 40 (2014)
35. Statistisches Bundesamt: Statistisches Jahrbuch 2010. Wiesbaden (2010)
36. Statistisches Bundesamt: Bevölkerung Deutschlands bis 2060. 12. koordinierte Bevölkerungsvorausberechnung. Wiesbaden (2009)
37. Fleming, D.M., Elliot, A.J.: Estimating the risk population in relation to influenza vaccination policy. Vaccine 24(20), 4378–4385 (2006)
38. Mossong, J., Hens, N., Jit, M., Beutels, P., Auranen, K., Mikolajczyk, R., Massari, M., Salmaso, S., Tomba, G.S., Wallinga, J., Heijne, J., Sadkowska-Todys, M., Rosinska, M., Edmunds, W.J.: Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 5(3), e74 (2008)
39. Chowell, G., Miller, M.A., Viboud, C.: Seasonal influenza in the United States, France, and Australia: transmission and prospects for control. Epidemiol. Infect. 136(6), 852–864 (2008)
40. Carrat, F., Vergu, E., Ferguson, N.M., Lemaitre, M., Cauchemez, S., Leach, S., Valleron, A.J.: Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am. J. Epidemiol. 167(7), 775–785 (2008)
41. Vynnycky, E., Pitman, R., Siddiqui, R., Gay, N., Edmunds, W.J.: Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine 26(41), 5321–5330 (2008)
42. Vesikari, T., Knuf, M., Wutzler, P., Karvonen, A., Kieninger-Baum, D., Schmitt, H.J., Baehner, F., Borkowski, A., Tsai, T.F., Clemens, R.: Oil-in-water emulsion adjuvant with influenza vaccine in young children. N. Engl. J. Med. 365(15), 1406–1416 (2011)
43. Jefferson, T., Di Pietrantonj, C., Al-Ansary, L.A., Ferroni, E., Thorning, S., Thomas, R.E.: Vaccines for preventing influenza in the elderly. Cochrane Database Syst. Rev. 2010(2), CD004876 (2010)
44. Monto, A.S., Ohmit, S.E., Petrie, J.G., Johnson, E., Truscon, R., Teich, E., Rotthoff, J., Boulton, M., Victor, J.C.: Comparative efficacy of inactivated and live attenuated influenza vaccines. N. Engl. J. Med. 361(13), 1260–1267 (2009)
45. Jefferson, T., Rivetti, A., Harnden, A., Di Pietrantonj, C., Demicheli, V.: Vaccines for preventing influenza in healthy children. Cochrane Database Syst. Rev. 2008(2), CD4879 (2008)
46. Rhorer, J., Ambrose, C.S., Dickinson, S., Hamilton, H., Oleka, N.A., Malinoski, F.J., Wittes, J.: Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine 27(7), 1101–1110 (2009)
47. Jefferson, T., Rivetti, A., Di Pietrantonj, C., Demicheli, V., Ferroni, E.: Vaccines for preventing influenza in healthy children. Cochrane Database Syst. Rev. 2012(8), CD4879 (2012)
48. ® Scientific product monograph 2010–2011. Gaithersburg (2010)
49. Ambrose, C.S., Yi, T., Falloon, J.: An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2–17 years. Influenza Other Respir. Viruses 5, 389–397 (2011)
50. Blank, P.R., Schwenkglenks, M., Szucs, T.D.: Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J. Infect. 58(6), 446–458 (2009)
51. Blank, P.R., Schwenkglenks, M., Szucs, T.D.: Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 8, 272 (2008)
52. Meier, C.R., Napalkov, P.N., Wegmüller, Y., Jefferson, T., Jick, H.: Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur. J. Clin. Microbiol. Infect. Dis. 19(11), 834–842 (2000)
53. Sessa, A., Costa, B., Bamfi, F., Bettoncelli, G., D‘Ambrosio, G.: The incidence, natural history and associated outcomes of influenza-like illness and clinical influenza in Italy. Fam. Pract. 18(6), 629–634 (2001)
54. Ewig, S., Birkner, N., Strauss, R., Schaefer, E., Pauletzki, J., Bischoff, H., Schraeder, P., Welte, T., Hoeffken, G.: New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 64(12), 1062–1069 (2009)
55. von Baum, H., Schweiger, B., Welte, T., Marre, R., Suttorp, N., Pletz, M.W., Ewig, S.: CAPNETZ Study Group: How deadly is seasonal influenza-associated pneumonia? The German competence network for community-acquired pneumonia. Eur. Respir. J. 37(5), 1151–1157 (2011)
56. Butler, C.C., Hood, K., Verheij, T., Little, P., Melbye, H., Nuttall, J., Kelly, M.J., Mölstad, S., Godycki-Cwirko, M., Almirall, J., Torres, A., Gillespie, D., Rautakorpi, U., Coenen, S., Goossens, H.: Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 338, b2242 (2009)
57. Zok K.: Arzneimittelmarkt: Selbstmedikation im Fokus. WIdO-Monitor 3(1), 1–7 (2006)
58. Abbas, S., Ihle, P., Heymans, L., Kupper-Nybelen, J., Schubert, I.: Differences in antibiotic prescribing between general practitioners and pediatricians in Hesse, Germany. Dtsch. Med. Wochenschr. 135(37), 1792–1797 (2010)
59. Weigl, J.A., Puppe, W., Rockahr, S., Schmitt, H.J.: Burden of disease in hospitalized RSV-positive children in Germany. Klin. Padiatr. 214(6), 334–342 (2002)
60. Ewig, S., Seifert, K., Kleinfeld, T., Göke, N., Schäfer, H.: Management of patients with community-acquired pneumonia in a primary care hospital: a critical evaluation. Respir. Med. 94(6), 556–563 (2000)
61. Lauer-Fischer GmbH: Lauer-Taxe (2012)
62. Kassenärztliche Bundesvereinigung: Einheitlicher Bewertungsmaßstab (EBM), Stand: 1. Quartal 2012. Berlin (2012)
63. Kassenärztliche Bundesvereinigung, GKV-Spitzenverband: Beschluss des Bewertungsausschusses nach § 87 Abs. 1 Satz 1 SGB V in seiner 266. Sitzung am 14. Dezember 2011 zur Weiterentwicklung der vertragsärztlichen Vergütung im Jahr 2012 (2011)
64. Institut für das Entgeltsystem im Krankenhaus GmbH (InEK): G-DRG-Fallpauschalen-Katalog 2012. Siegburg (2011)
65. Koopmanschap, M.A., Rutten, F.F., van Ineveld, B.M., van Roijen, L.: The friction cost method for measuring indirect costs of disease. J. Health Econ. 14(2), 171–189 (1995)
66. Bundesagentur für Arbeit: Arbeitsmarkt 2010. Amtliche Nachrichten der Bundesagentur für Arbeit, 58. Jahrgang, Sondernummer 2 Nürnberg (2011)
67. AOK-Bundesverband: Krankheitsartenstatistik des AOK-Bundesverbandes. Arbeitsunfähigkeit bei AOK-Pflichtmitgliedern ohne Rentner. Berlin (2009)
68. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWIG): Allgemeine Methoden zur Bewertung von Verhältnissen zwischen Nutzen und Kosten. Köln (2009)
69. Mauskopf, J.A., Cates, S.C., Griffin, A.D., Neighbors, D.M., Lamb, S.C., Rutherford, C.: Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in Australia. Pharmacoeconomics 17(6), 611–620 (2000)
70. Talbird, S.E., Brogan, A.J., Winiarski, A.P., Sander, B.: Cost-effectiveness of treating influenza like illness with oseltamivir in the United States. Am. J. Health Syst. Pharm. 66(5), 469–480 (2009)
71. Hinz, A., Klaiberg, A., Brähler, E., König, H–.H.: Der Lebensqualitätsfragebogen EQ-5D: Modelle und Normwerte für die Allgemeinbevölkerung. Psychother. Psychosom. Med. Psychol. 56(2), 42–48 (2006)
72. Robert Koch-Institut (RKI): Schätzung der Influenza-bedingten Todesfälle während der Saison 2008/09 und der pandemischen Saison 2009/10. Epidemiol. Bull. 2011(10), 75–77 (2011)
73. Zucs, P., Buchholz, U., Haas, W., Uphoff, H.: Influenza associated excess mortality in Germany, 1985–2001. Emerg. Themes Epidemiol. 2, 6 (2005)
74. Nichol, K.L.: Cost-effectiveness and socio-economic aspects of childhood influenza vaccination. Vaccine 29(43), 7554–7558 (2011)
75. Savidan, E., Chevat, C., Marsh, G.: Economic evidence of influenza vaccination in children. Health Policy 86(2–3), 142–152 (2008)
76. Dayan, G.H., Nguyen, V.H., Debbag, R., Gomez, R., Wood, S.C.: Cost-effectiveness of influenza vaccination in high-risk children in Argentina. Vaccine 19(30), 4204–4213 (2001)
77. Meltzer, M.I., Neuzil, K.M., Griffin, M.R., Fukuda, K.: An economic analysis of annual influenza vaccination of children. Vaccine 23(8), 1004–1014 (2005)
78. White, T., Lavoie, S., Nettleman, M.D.: Potential cost savings attributable to influenza vaccination of school-aged children. Pediatrics 103(6), e73 (1999)
79. Marchetti, M., Kühnel, U.M., Colombo, G.L., Esposito, S., Principi, N.: Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age. Hum. Vaccin. 3(1), 14–22 (2007)
80. Salo, H., Kilpi, T., Sintonen, H., Linna, M., Peltola, V., Heikkinen, T.: Cost-effectiveness of influenza vaccination of healthy children. Vaccine 24(23), 4934–4941 (2006)
81. Skowronski, D.M., Woolcott, J.C., Tweed, S.A., Brunham, R.C., Marra, F.: Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada. Vaccine 24(19), 4222–4232 (2006)
82. Luce, B.R., Nichol, K.L., Belshe, R.B., Frick, K.D., Li, S.X., Boscoe, A., Rousculp, M.D., Mahadevia, P.J.: Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States. Vaccine 26(23), 2841–2848 (2008)
83. Prosser, L.A., Bridges, C.B., Uyeki, T.M., Hinrichsen, V.L., Meltzer, M.I., Molinari, N.A., Schwartz, B., Thompson, W.W., Fukuda, K., Lieu, T.A.: Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg. Infect. Dis. 12(10), 1548–1558 (2006)
84. Cohen, G.M., Nettleman, M.D.: Economic impact of influenza vaccination in preschool children. Pediatrics 106(5), 973–976 (2000)
85. Giglio, N., Gentile, A., Lees, L., Micone, P., Armoni, J., Reygrobellet, C., Crepey, P.: Public health and economic benefits of new pediatric influenza vaccination programs in Argentina. Hum. Vaccin. Immunother. 8(3), 312–322 (2012)
86. Weycker, D., Edelsberg, J., Halloran, M.E., Longini Jr, I.M., Nizam, A., Ciuryla, V., Oster, G.: Population-wide benefits of routine vaccination of children against influenza. Vaccine 23(10), 1284–1293 (2005)
87. Pabst, L.J., Fiore, A.E., Cullen, K.A.: Completion of the 2-dose influenza vaccine series among children aged 6 to 59 months: immunization information system sentinel sites, 2007–2008 influenza season. Clin. Pediatr. (Phila.) 50(11), 1068–1070 (2011)
88. Jackson, L.A., Neuzil, K.M., Baggs, J., Davis, R.L., Black, S., Yamasaki, K.M., Belongia, E., Zangwill, K.M., Mullooly, J., Nordin, J., Marcy, S.M., DeStefano, F.: Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study. Pediatrics 118(5), 2032–2037 (2006)
89. Block, S.L., Toback, S.L., Yi, T., Ambrose, C.S.: Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years. Clin. Ther. 31(10), 2140–2147 (2009)